Omkar U. Kawalekar, PhD, is a manager in Deloitte’s Strategy & Analytics Consulting practice, primarily focusing on life sciences. He leads several initiatives for the firm’s NextGen Therapy practice, specializing in cell and gene therapies. In the last five years, Kawalekar has worked closely with executives at biopharma companies, defining and implementing transformative capabilities as they develop, manufacture, and commercialize such innovative therapies. He leads the eminence workstream of the NextGen Therapy practice, and has presented at numerous scientific conferences in oncology, gene therapy, and CAR-TCR therapy. Connect with Kawalekar on LinkedIn at https://www.linkedin.com/in/omkar-kawalekar-7406887/.